from

Ultima Markets and Inter Bring Their Partnership from Screen to Stadium

MILAN, Oct. 31, 2025 /PRNewswire/ -- Ultima Markets celebrated its Regional Partnership for the Asian territory with FC Internazionale Milano…

1 month ago

The global campaign ‘7 Wonders of Future Cities’ from New7Wonders starts on World Cities Day

DUBAI, UAE, Oct. 30, 2025 /PRNewswire/ -- New7Wonders, the world's official authority for public voting to choose Wonders, today formally…

1 month ago

Saudi Arabia Redefines Wealth in Shift From Oil Dependence

RIYADH, Saudi Arabia, Oct. 30, 2025 /PRNewswire/ -- In an analytical article published in Asharq Al-Awsat titled "How is Saudi…

1 month ago

InSolare Energy Wins 600 MW / 1,200 MWh BESS Project from SECI — One of the Largest Standalone Awards to Date, Strengthening Its Leadership in Net Zero Infrastructure

InSolare, the 16-year-old clean energy leader extends its legacy of innovation with India's latest grid-scale storage milestone. MUMBAI, India, Oct.…

1 month ago

Solidion Technology Secures $1 Million Non-Dilutive Bridge Financing from Existing Shareholder

Company Reaffirms Commitment to Protect Shareholder Value and Pursue Strategic, Long-Term Capital Partners DALLAS, Oct. 30, 2025 /PRNewswire/ -- Solidion Technology…

1 month ago

Goyaz Secures Series A Investment from Norwest

HYDERABAD, India, Oct. 30, 2025 /PRNewswire/ -- Goyaz, India's fastest-growing occasion-led gold-plated silver jewelry brand, today announced the successful closure of…

1 month ago

LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE

Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial…

1 month ago

Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets

First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and…

1 month ago

From India to the USA: HDFC ERGOs Guide to Why Travel Insurance is Essential

mumbai, India, Oct. 25, 2025 (GLOBE NEWSWIRE) --  A long flight, a new time zone, and unfamiliar rules can turn…

1 month ago

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

1 month ago